or
forgot password
  • cancer clinical trials in nebraska

  • Biomarkers That Predict Response to High-Dose Aldesleukin in Patients With Metastatic Kidney Cancer or Metastatic Melanoma
    UNMC Eppley Cancer Center at the University of Nebraska Medical Center
    Omaha, Nebraska 68198-7680
    Kidney Cancer, Melanoma (Skin)
    Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
    Nebraska Methodist Cancer Center
    Omaha, Nebraska 68114
    Non-Small Cell Lung Cancer
    Sorafenib Long Term Extension Program (STEP)

    Omaha, Nebraska 68114
    Neoplasms
    CT Scans in Screening for Lung Cancer in Current and Former Smokers
    UNMC Eppley Cancer Center at the University of Nebraska Medical Center
    Omaha, Nebraska 68198-7680
    Lung Cancer
    Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
    Nebraska Medical Center
    Omaha, Nebraska 68198
    Hepatic Veno-Occlusive Disease
    Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer
    Southeast Nebraska Hematology Oncology Consultants at Southeast Nebraska Cancer Center

    Trial Locations
    Southeast Nebraska Hematology Oncology Consultants at Southeast Nebraska Cancer Center
    CCOP - Missouri Valley Cancer Consortium
    Breast Cancer
    Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
    Methodist Estabrook Cancer Center

    Trial Locations
    Methodist Estabrook Cancer Center
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Nebraska Methodist Hospital
    Lakeside Hospital
    Lung Cancer
    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
    Internal Medical Associates Of Grand Island, P.C

    Trial Locations
    Internal Medical Associates Of Grand Island, P.C
    Creighton University Medical Center
    Venous Thrombosis
    Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
    Methodist Estabrook Cancer Center

    Trial Locations
    Methodist Estabrook Cancer Center
    Lakeside Hospital
    Esophageal Cancer
    A Breast Cancer Information Registry for Participants With Breast Cancer or Characteristics of Hereditary Breast Cancer
    Good Samaritan Hospital/Cancer Center

    Trial Locations
    Good Samaritan Hospital/Cancer Center
    St. Elizabeth's Regional Medical Center
    UNMC Eppley Cancer Center at the University of Nebraska Medical Center
    Breast Cancer, Precancerous Condition
    Combination Chemotherapy and Bevacizumab in Treating Women With HER2/Neu-Negative Stage II or Stage III Breast Cancer
    UNMC Eppley Cancer Center at the University of Nebraska Medical Center
    Omaha, Nebraska 68198-7680
    HER2-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
    S0713: Oxaliplatin, Capecitabine, Cetuximab, and RT Followed By Surgery in Pts W/Stage II or III Rectal Cancer
    Good Samaritan Cancer Center at Good Samaritan Hospital
    Kearney, Nebraska 68848-1990
    Colorectal Cancer
    A Phase 1 Safety Study of LY2127399 in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Relapsed or Refractory Multiple Myeloma
    Collaborative Registry of Patients With Thyroid Cancer and/or Thyroid Tumors
    Clinical Trials Patient Advocate Office
    Omaha, Nebraska 68198
    Neoplasms, Thyroid
    Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
    Lincoln Medical Education Foundation Cancer Resource Center

    Trial Locations
    Lincoln Medical Education Foundation Cancer Resource Center
    Great Plains Regional Medical Center
    University of Nebraska Medical Center
    Methodist Estabrook Cancer Center
    Creighton University Medical Center
    Alegent Health Immanuel Medical Center
    Alegent Health Bergan Mercy Medical Center
    Missouri Valley Cancer Consortium CCOP
    Alegent Health Lakeside Hospital
    Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer
    ImClone Investigational Site
    Grand Island, Nebraska 68803
    Breast Cancer
    Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
    Nebraska Methodist Hospital
    Omaha, Nebraska 68114
    Thyroid Cancer
    Diet and Physical Activity Change or Usual Care in Improving Survival in Patients With Previously Treated Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Methodist Estabrook Cancer Center
    Omaha, Nebraska 68114-4199
    Cognitive/Functional Effects, Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer, Weight Changes
    American Ginseng in Treating Patients With Fatigue Caused by Cancer
    Cancer Resource Center - Lincoln

    Trial Locations
    Cancer Resource Center - Lincoln
    CCOP - Missouri Valley Cancer Consortium
    Immanuel Medical Center
    Creighton University Medical Center
    Alegant Health Cancer Center at Bergan Mercy Medical Center
    Chronic Myeloproliferative Disorders, Fatigue, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Unspecified Adult Solid Tumor, Protocol Specific
    Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Renal Cell Carcinoma
    Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
    Southeast Nebraska Hematology & Oncology Consultants
    Lincoln, Nebraska 68516
    Pancreatic Cancer
    Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site
    Nebraska Methodist Cancer Center
    Omaha, Nebraska 68114
    Carcinoma
    Pemetrexed or Erlotinib as Second-Line Therapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
    Good Samaritan Hospital
    Kearney, Nebraska 68847
    Recurrent Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary
    Methodist Estabrook Cancer Center
    Omaha, Nebraska 68114-4199
    Ovarian Stromal Cancer
    Efficacy and Safety Study of OncoVEXGM-CSF Compared to GM-CSF in Melanoma
    Methodist Estabrook Cancer Center
    Omaha, Nebraska 68114-4199
    Melanoma
    Neuropsychological and Behavioral Testing in Young Patients With Cancer
    University of Nebraska Medical Center
    Omaha, Nebraska 68198-3330
    Chemotherapeutic Agent Toxicity, Cognitive/Functional Effects, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment, Radiation Toxicity, Unspecified Childhood Solid Tumor, Protocol Specific
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Good Samaritan Hospital

    Trial Locations
    Good Samaritan Hospital
    Lincoln Medical Education Foundation Cancer Resource Center
    Methodist Estabrook Cancer Center
    Creighton University Medical Center
    Alegent Health Immanuel Medical Center
    Alegent Health Bergan Mercy Medical Center
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer